novonordisk.com Report : Visit Site

Technical data of the novonordisk.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host novonordisk.com. Currently, hosted in Hong Kong and its service provider is Novo Nordisk A/S (NextWeb) IP Space .

the related websites

wyg.com annualreport2011.nibc.com portswigger.net beneteau.com cimaglobal.com us.macmillan.com fredperry.com idodi.org iaeste.org theelders.org peaceoneday.org emirates.com karmaloop.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

please use google chrome when browsing novonordisk.com or any other external website in novo nordisk. you can read more about google chrome for work here back patients patients diabetes care diabetes care type 1 type 2 gestational diabetes pens, needles and injection support obesity and weight management obesity and weight management the science behind obesity the power of non scale victories haemophilia haemophilia living with haemophilia understanding haemophilia hormone replacement therapy hormone replacement therapy growth hormone therapy growth hormone therapy is my child growing normally? what is growth hormone? growth hormone pens patient organisations disease experience expert panel (deep) disease experience expert panel (deep) deep news: a partnership that benefits patients r&d; r&d; inside r&d; inside r&d; core capabilities protein expertise bioethics life science r&d; partnerships r&d; partnerships r&d; patient partnering innovation partnering contact disease areas disease areas type 1 diabetes type 2 diabetes obesity haemophilia growth disorders r&d; pipeline the r&d; pipeline reflects our long-term commitment to driving change to defeat obesity, haemophilia, growth disorders and other serious chronic diseases r&d; facts and figures facts and figures specific to our research & development organisation sustainable business sustainable business access to care access to care access to insulin commitment humanitarian action changing diabetes® in children reaching the base of the pyramid changing diabetes® in pregnancy no empty shelves global advocacy world diabetes foundation novo nordisk haemophilia foundation environmental responsibility environmental responsibility reducing carbon emissions water stewardship waste management responsible business practices responsible business practices human rights bioethics business ethics and anti-corruption responsible sourcing integrated reporting how we report our financial, social and environmental performance positions, principles and policies what guides the way we do business the sustainable development goals how we contribute to the sustainable development goals careers careers join us available jobs email job agent unsolicited applications working at novo nordisk moving to denmark meet us - event calendar professionals research & development manufacturing corporate functions finance, legal & ir it career programmes phd and postdocs medical doctors graduates, students and trainees graduates students trainees - elev about novo nordisk  media products investors partnering contact us novo nordisk worldwide the exciting potential of stem cell research mads krogsgaard thomsen, cso of novo nordisk, considers the potential of stem cell-based therapies to cure type 1 diabetes and other chronic diseases read mads’ perspective managing diabetes during ramadan how can you balance health & faith during ramadan? get tips here closer to nature want to find out why getting as close as possible to the real thing with insulin treatment matters to people with diabetes? go here perspectives features and points of view from novo nordisk and the society we serve explore our perspectives subscribe to perspectives important safety information about colour change for fiasp ® flextouch ® and fiasp ® penfill ® read more about the issue news oral semaglutide shows superior improvement in hba1c vs empagliflozin in the pio... 29 may 2018 real-world evidence shows clinically meaningful weight loss in people receiving ... 24 may 2018 read more news we offer 0 job opportunities denmark (75) china (128) algeria (3) austria (1) bosnia & herzegovina (1) brazil (8) canada (8) chile (1) dominican republic (1) france (8) gabon (1) germany (2) india (40) indonesia (2) iraq (5) israel (9) kenya (1) malaysia (4) mexico (3) morocco (4) nederland (1) nigeria (1) norway (1) philippines (3) russia (5) south africa (4) south korea (1) spain (3) switzerland (1) thailand (1) tunisia (1) ukraine (3) united arab emirates (1) united kingdom (6) vietnam (3) denmark (67) china (21) algeria (3) austria (1) bosnia & herzegovina (1) brazil (1) canada (8) chile (1) dominican republic (1) france (7) gabon (1) germany (4) india (40) indonesia (2) iraq (5) israel (9) kenya (1) malaysia (2) mexico (3) morocco (4) nederland (1) nigeria (1) norway (1) philippines (3) russia (4) south africa (3) south korea (1) spain (1) thailand (1) ukraine (3) united kingdom (6) vietnam (3) search overview who we are novo nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. this heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases. headquartered in denmark, novo nordisk employs approximately 42,700 people in 79 countries and markets its products in more than 170 countries. novo nordisk websites novo nordisk in the usa novo nordisk in denmark or choose: affiliate sites usa algeria argentina australia austria belgium brazil bulgaria canada chile china colombia croatia czech republic denmark estonia finland france germany greece hong kong hungary india ireland israel italy japan latvia lithuania mexico moldova netherlands new zealand norway pakistan poland portugal russia saudi arabia serbia slovakia slovenia south korea spain sweden switzerland taiwan tunisia turkey ukraine united kingdom usa venezuela other sites cities changing diabetes clinical trials dawn study hero study novo holdings a/s novo nordisk foundation novo nordisk haemophilia foundation novo nordisk pharmatech a/s world diabetes foundation novo nordisk worldwide addresses and global contacts important safety information about novopen echo ® and novopen ® 5 read more about the issue shareholder information share info annual reporting annual report 2017 contact quick links contact customer services in your country report a side effect report product complaints report falsified products report a concern to the compliance hotline media contact © 2018 novo nordisk a/s disclaimer/privacy sitemap

URL analysis for novonordisk.com

https://www.novonordisk.com/sustainable-business/performance-on-tbl/access-to-care/changing-diabetes-in-children.html
https://www.novonordisk.com/careers/professionals/it.html
https://www.novonordisk.com/patients/growth-hormone-therapy/what-is-growth-hormone.html
https://www.novonordisk.com/media/news-details.2194776.html
https://www.novonordisk.com/sustainable-business/performance-on-tbl/responsible-business-practices/responsible-sourcing.html
https://www.novonordisk.com/careers/professionals/finance-legal-ir.html
https://www.novonordisk.com/rnd/inside-r-d/bioethics.html
https://www.novonordisk.com/patients/growth-hormone-therapy/patient-organisations.html
https://www.novonordisk.com/careers/working-at-novo-nordisk/email-job-agent.html
https://www.novonordisk.com/investors/shareinformation/share-monitor.html
https://www.novonordisk.com/closer-to-nature/index.html
https://www.novonordisk.com/patients/diabetes-care/gestational-diabetes.html
https://www.novonordisk.com/sustainable-business/performance-on-tbl/access-to-care/reaching-the-base-of-the-pyramid.html
https://www.novonordisk.com/about-novo-nordisk/novo-nordisk-in-brief/stories/citizenship/managing-diabetes-during-ramadan.html
https://www.novonordisk.com/rnd.html

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: novonordisk.com
Registry Domain ID: 2011417_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.ascio.com
Registrar URL: http://www.ascio.com
Updated Date: 2016-08-24T22:38:44Z
Creation Date: 1998-09-21T00:00:00Z
Registrar Registration Expiration Date: 2017-09-20T04:00:00Z
Registrar: Ascio Technologies, Inc
Registrar IANA ID: 106
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +44.2070159370
For more information on Whois status codes, please visit https://icann.org/epp
Domain Status: OK
Registry Registrant ID:
Registrant Name: Domain Manager
Registrant Organization: Novo Nordisk A/S
Registrant Street: Novo Alle
Registrant City: Bagsvaerd
Registrant State/Province:
Registrant Postal Code: 2880
Registrant Country: DK
Registrant Phone: +45.44448888
Registrant Phone Ext:
Registrant Fax: +45.44442314
Registrant Fax Ext:
Registrant Email: [email protected]
Registry Admin ID:
Admin Name: Domain Manager
Admin Organization: NNIT A/S
Admin Street: Krogshoejvej 45
Admin City: Bagsvaerd
Admin State/Province: DK
Admin Postal Code: 2880
Admin Country: DK
Admin Phone: +45.44424242
Admin Phone Ext:
Admin Fax: +45.44982866
Admin Fax Ext:
Admin Email: [email protected]
Registry Tech ID:
Tech Name: Domain Manager
Tech Organization: NNIT A/S
Tech Street: Krogshoejvej 45
Tech Street: PO BOX 8600
Tech City: Bagsvaerd
Tech State/Province:
Tech Postal Code: 2880
Tech Country: DK
Tech Phone: +45.44424242
Tech Phone Ext:
Tech Fax: +45.44982866
Tech Fax Ext:
Tech Email: [email protected]
Name Server: ns1.novonordisk.com
Name Server: ns2.novonordisk.com
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2017-07-09T22:01:44 UTC <<<

The data in Ascio Technologies' WHOIS database is provided
by Ascio Technologies for information purposes only. By submitting
a WHOIS query, you agree that you will use this data only for lawful
purpose. In addition, you agree not to:
(a) use the data to allow, enable, or otherwise support any marketing
activities, regardless of the medium used. Such media include but are
not limited to e-mail, telephone, facsimile, postal mail, SMS, and
wireless alerts; or
(b) use the data to enable high volume, automated, electronic processes
that sendqueries or data to the systems of any Registry Operator or
ICANN-Accredited registrar, except as reasonably necessary to register
domain names or modify existing registrations.
(c) sell or redistribute the data except insofar as it has been
incorporated into a value-added product or service that does not permit
the extraction of a substantial portion of the bulk data from the value-added
product or service for use by other parties.
Ascio Technologies reserves the right to modify these terms at any time.
Ascio Technologies cannot guarantee the accuracy of the data provided.
By accessing and using Ascio Technologies WHOIS service, you agree to these terms.

  REGISTRAR ASCIO TECHNOLOGIES, INC. DANMARK - FILIAL AF ASCIO TECHNOLOGIES, INC. USA

  REFERRER http://www.ascio.com

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =novonordisk.com

  PORT 43

  SERVER whois.ascio.com

  ARGS novonordisk.com

  PORT 43

  TYPE domain

DOMAIN

  NAME novonordisk.com

NSERVER

  NS1.NOVONORDISK.COM 217.16.101.177

  NS2.NOVONORDISK.COM 217.24.83.194

STATUS
ok https://icann.org/epp#ok

  CHANGED 2016-08-24

  CREATED 1998-09-21

  EXPIRES 2017-09-20

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .